General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0PCGKN
ADC Name
hu5B1-TCO
Synonyms
hu5B1-TCO; hu5B1 TCO; hu5B1TCO
   Click to Show/Hide
Organization
Memorial Sloan Kettering Cancer Center
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Pancreatic cancer
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
hu5B1
 Antibody Info 
Antigen Name
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
Undisclosed